Oncology

The Hong Kong Department of Health has approved tisotumab vedotin-tftv (Tivdak) as a treatment for adults with metastatic or recurrent cervical cancer...

The combination of venetoclax (Venclexta) plus azacitidine did not improve overall survival (OS) compared with placebo plus azacitidine in patients wi...

At the Society of Hematologic Oncology 2025 Annual Meeting, CancerNetwork® spoke with Francesca Palandri, MD, PhD, an adjunct professor in the Departm...

Statistically significant reductions in all-cause mortality, progression to myelofibrosis, and venous thromboembolism (VTE) occurred among patients wi...

Casali PG, Blay JY, Abecassis N, Bajpai J, Bauer S, Biagini R, et al. Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidel...

Currently, breast cancer is the most diagnosed form of cancer amongst American women [1]. Most subtypes of breast cancer are driven by estrogen recept...

Pleural mesothelioma (PM) is a very aggressive malignancy that arises from the mesothelial cells lining the pleural cavity [1]. It is often associated...

The time duration from diagnosis to treatment initiation (DTI), also referred to as the treatment interval in the Aarhus statement [1], is a crucial c...

Mirvetuximab soravtansine-gynx (Elahere) has been approved by Health Canada as an injection for patients with folate receptor-alpha (FRα)–positive pla...

Study population The NHSII [24] was established in 1989 with 116,429 female registered nurses aged 25–42 years enrolled. Participants were followed by...